Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study conducted in Europe. The aim of this study is to evaluated the use of insulin
detemir (Levemir®) in insufficiently controlled patients with type 1 or type 2 diabetes.